These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2901939)

  • 1. Serum pepsinogen I in familial multiple endocrine neoplasia type I.
    Lamers CB; Rotter JI; Jansen JB; Samloff IM
    Dig Dis Sci; 1988 Oct; 33(10):1274-6. PubMed ID: 2901939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretin-stimulated serum gastrin levels in hyperparathyroid patients from families with multiple endocrine adenomatosis type I.
    Lamers CB; Buis JT; van Tongeren J
    Ann Intern Med; 1977 Jun; 86(6):719-24. PubMed ID: 17340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypergastrinemia in familial multiple endocrine adenomatosis.
    Synder N; Scurry M; Hughes W
    Ann Intern Med; 1974 Mar; 80(3):321-5. PubMed ID: 4150177
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyperparathyroidism: a prerequisite for Zollinger-Ellison syndrome in multiple endocrine adenomatosis Type 1--report of a further family and a review of th literature.
    Betts JB; O'Malley BP; Rosenthal FD
    Q J Med; 1980; 49(193):69-76. PubMed ID: 6107954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum concentrations of immunoreactive calcitonin in patients with hypergastrinaemia.
    Lamers CB; Hackeng WH; Thien T; van Tongeren JH
    Digestion; 1980; 20(6):379-82. PubMed ID: 6105986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum gastrin level is increased by chronic hypercalcemia of parathyroid or nonparathyroid origin.
    Zaniewski M; Jordan PH; Yip B; Thornby JI; Mallette LE
    Arch Intern Med; 1986 Mar; 146(3):478-82. PubMed ID: 2869739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing for Multiple Endocrine Neoplasia Type 1 in Patients Evaluated for Zollinger-Ellison Syndrome-Clues to a Safer Diagnostic Process.
    Singh Ospina N; Donegan D; Rodriguez-Gutierrez R; Al-Hilli Z; Young WF
    Am J Med; 2017 May; 130(5):603-605. PubMed ID: 28011308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical value of determining pepsinogen I].
    Griessen M; Male PJ; Infante F; Jodry H; Loizeau E
    Schweiz Med Wochenschr; 1984 Dec; 114(49):1849-51. PubMed ID: 6515384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum group I pepsinogens by radioimmunoassay in control subjects and patients with peptic ulcer.
    Samloff IM; Liebman WM; Panitch NM
    Gastroenterology; 1975 Jul; 69(1):83-90. PubMed ID: 1150038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of pancreatic polypeptide in Zollinger-Ellison syndrome, and hyperparthyroidism from families with multiple endocrine adenomatosis type I.
    Lamers CB; Diemel J; Roeffen W
    Digestion; 1978; 18(5-6):297-302. PubMed ID: 35434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duodenal-ulcer disease associated with elevated serum pepsinogen I: an inherited autosomal dominant disorder.
    Rotter JI; Sones JQ; Samloff IM; Richardson CT; Gursky JM; Walsh JH; Rimoin DL
    N Engl J Med; 1979 Jan; 300(2):63-6. PubMed ID: 758579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of effect of parathyroidectomy or calcium channel blockade on serum gastrin concentration and gastric acid secretion in a patient with hyperparathyroidism and Zollinger-Ellison syndrome.
    Stevens MH; Thirlby RC; Richardson CT
    Surgery; 1987 Jan; 101(1):108-13. PubMed ID: 3798319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypergastrinemia. Physiopathological and clinical aspects with a study of a series of Zollinger-Ellison cases].
    Fiasse R; De Graef J; Pauwels S; Woussen-Colle MC; Rahier J; Kestens PJ; Dive C
    Acta Gastroenterol Belg; 1982; 45(7-8):293-309. PubMed ID: 6132512
    [No Abstract]   [Full Text] [Related]  

  • 14. [Duodenal ulcer and hypergastrinemia; differential diagnosis and possibilities of surgical treatment].
    Bollen EC; van Knippenberg LA
    Ned Tijdschr Geneeskd; 1983 Jan; 127(3):99-104. PubMed ID: 6131384
    [No Abstract]   [Full Text] [Related]  

  • 15. Parathyroid mitogenic activity in plasma from patients with familial multiple endocrine neoplasia type 1.
    Brandi ML; Aurbach GD; Fitzpatrick LA; Quarto R; Spiegel AM; Bliziotes MM; Norton JA; Doppman JL; Marx SJ
    N Engl J Med; 1986 May; 314(20):1287-93. PubMed ID: 2871488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperparathyroidism and hypergastrinemia revisited.
    Primrose JN; Joffe SN
    Surgery; 1984 Dec; 96(6):1144-50. PubMed ID: 6505967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide hormone markers in screening for endocrine tumors in multiple endocrine adenomatosis type I.
    Oberg K; Wälinder O; Boström H; Lundqvist G; Wide L
    Am J Med; 1982 Nov; 73(5):619-30. PubMed ID: 6127949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-to-date treatment of the patient with hypergastrinemia.
    Townsend CM; Thompson JC
    Adv Surg; 1987; 20():155-81. PubMed ID: 2877545
    [No Abstract]   [Full Text] [Related]  

  • 19. Characteristics of teen-age patients with juvenile duodenal ulcer. Relation between inherited hyperpepsinogenemia I and duodenal ulcer.
    Kimura M; Uemura N; Sumii K; Inbe A; Yosihara M; Haruma K; Kajiyama G
    Scand J Gastroenterol; 1993 Jan; 28(1):25-30. PubMed ID: 8430271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretin and calcium provocative tests in the Zollinger-Ellison syndrome. A prospective study.
    Frucht H; Howard JM; Slaff JI; Wank SA; McCarthy DM; Maton PN; Vinayek R; Gardner JD; Jensen RT
    Ann Intern Med; 1989 Nov; 111(9):713-22. PubMed ID: 2572194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.